¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (1ÀÏÂ÷) : 2023-06-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (1ÀÏÂ÷) : 2023-06-16
±³À°ÀÏÀÚ : 2023-06-16
±³À°Àå¼Ò : ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ

±³À°ÁÖÁ¦ : 2023 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹¸Á¸·ÇÐȸ

´ã´çÀÚ : ¹ÚÀ±Á¤
¿¬¶ôó : 02-471-6520

À̸ÞÀÏ : retina@retina.or.kr

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 2Á¡

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 2 ½Ã°£ 34ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:10~08:17 [ÃʷϹßÇ¥] Cardiovascular and cerebrovascular adverse events associated with intravitreal anti-vascular endothelial growth factor monoclonal antibodies: a World Health Organization pharmacovigileance study ¾çÁö¸í(µ¿±¹´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:17~08:24 [ÃʷϹßÇ¥] Morbidity and Mortality in Patients with Unrecognized Type 2 Diabetes Mellitus and Diabetic Retinopathy: A Population-based Cohort Study ¹è°ÇÈ£(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:24~08:31 [ÃʷϹßÇ¥] The risk of retinal vein occlusion in young patients with mental disorders: A Nationwide Cohort Study ÀÌÁö¿µ(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:31~08:38 [ÃʷϹßÇ¥] Äڷγª19 °¨¿° ȤÀº ¹é½Å Á¢Á¾°ú ¸Á¸·Ç÷°üÆó¼â ¹ß»ý°úÀÇ ¿¬°ü¼º ±è¿ëÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:38~08:45 [ÃʷϹßÇ¥] Screening Practice Pattern of Tamoxifen retinopathy and Pentosan Polysulfate Maculopathy: A Nationwide Population-Based Study using Korean National Health Claim Database ¾È¼ºÁØ(ÇѾç´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:45~08:52 [ÃʷϹßÇ¥] Association between Glycemic Status and Age-related Macular Degeneration: A Nationwide Population-Based Cohort Study ÀÌÇü¿ì(°Ç±¹´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:52~08:59 [ÃʷϹßÇ¥] Management of reactivated ROP after anti-VEGF injection ÀåÁöÇý(°è¸í´ë)

ÈÞ½Ä 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 08:59~09:10 Break time ()

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:10~09:17 [ÃʷϹßÇ¥] ºû¿¡ ¹ÝÀÀÇÏ´Â ¼±ÅÃÀû ÀÏ»êÈ­Áú¼Ò Àü´Þü¸¦ ÀÌ¿ëÇÑ ¸Á¸·Ç÷°üÆó¼â Ä¡·áÁ¦ °³¹ß ÀÌÁØ¿±(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:17~09:24 [ÃʷϹßÇ¥] HuD regulates alpha Crystallin A in diabetic neuro-retinal degeneration ¹Ú¿µÈÆ(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:24~09:31 [ÃʷϹßÇ¥] Single-cell transcriptome of the retinal pigment epithelium in cellular senescence Á¤Çý¿ø(°Ç±¹´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:31~09:38 [ÃʷϹßÇ¥] Exosomal miRNA-146a-5p as potential targets for dry age-related macular degeneration ±èÀ±Àü(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:38~09:45 [ÃʷϹßÇ¥] Intravitreal administration of exosomes derived from human retinal organoids alleviates photoreceptor degeneration in RCS rats by targeting the MAPK pathway ÇÑÁ¤¿ì(¼øõÇâ´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:45~09:52 [ÃʷϹßÇ¥] Factors related to central nervous system progression in primary vitreoretinal lymphoma ±èÁÖ¿µ(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:52~09:59 [ÃʷϹßÇ¥] Á¤»óÀΰú º¸Å©Æ®-°í¾ß³ª±â-Ç϶ó´Ùº´ ȯÀÚ¿¡¼­ ¸Æ¶ô¸· °í¹Ý»çÁ¡ ºÐÆ÷ÀÇ Â÷ÀÌ ±è¿µÈ£(°í·Á´ë)

ÈÞ½Ä 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 09:59~10:10 Break time ()

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:10~10:17 [ÃʷϹßÇ¥] ´Ü¾È RAP ȯÀÚ¿¡¼­ ¹Ý´ë¾È RAP ¹ß»ýÀ» AI°¡ ¿¹ÃøÇÒ ¼ö ÀÖÀ»±î? À±¿øÅÂ(±è¾È°úº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:17~10:24 [ÃʷϹßÇ¥] Production of fake fundus images using generative adversarial network Á¶¹üÁÖ(ÇѸ²´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:24~10:31 [ÃʷϹßÇ¥] Perception of Scotomas: from the Perspective of Artificial Vision ÀӸżø(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:31~10:38 [ÃʷϹßÇ¥] Factors affecting optical coherence tomography angiography signal strength index in patients receiving intravitreal injection treatment ±è¿ë±Ô(ÇѸ²´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:31~10:45 [ÃʷϹßÇ¥] Developing and evaluating an artificial intelligence-based computer-aided diagnosis system for retinal disease Ȳ´öÁø(Çѱæ¾È°úº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:45~10:52 [ÃʷϹßÇ¥] The alteration of perivascular reflectivity on optical coherence tomography in branched retinal vein obstruction Ȳº¸ÀÎ(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 16ÀÏ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼Ç2Ȧ 10:52~10:59 [ÃʷϹßÇ¥] Prevalence and ultrawidefield-guided swept-source optical coherence tomography image of peripheral retinal degeneration in young myopic patients Àü¼ÒÈñ(Ä«À̾Ȱú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (1ÀÏÂ÷) : 2023-06-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2023-06-16
´ÙÀ½±Û Ãá°èÇмú´ëȸ: Çѱ¹ ÀÇ·áÇöÀå¿¡¼­ÀÇ ÀÚ±â°áÁ¤±Ç : 2023-06-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 9 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 15 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 17 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 14 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 11 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 7 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 3 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 5 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 5 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 6 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 3 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 12 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 4 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 8 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 7 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷